Brazil Halts the Final Stage China Vaccine Trial, Claims Serious Adverse Reaction
The Brazilian National Health Surveillance Agency on Monday announced that it has suspended the clinical trials of China's Sinovac COVID-19 vaccines, citing "serious adverse reactions" that occurred during the testing last month (29 October), But the authority did not provide further details, nor explained why it took more than a week to announce the problem.
Sinovac Biotech has been cooperating with Butantan, an institute at the State of Sao Paulo, to develop COVID-19 vaccines, called CoronaVac. The institute was surprised by ANVISA's decision, said it said was investigating the incident and will held a press conference on Tuesday morning local time.
#China #Brazil #SaoPaulo #SinovacBiotech #Butantan #CoronaVac #ANVISA #COVID19 #WuhanVirus #Vaccine
Source: Stand News #Nov10
https://bit.ly/2H6uwYI
The Brazilian National Health Surveillance Agency on Monday announced that it has suspended the clinical trials of China's Sinovac COVID-19 vaccines, citing "serious adverse reactions" that occurred during the testing last month (29 October), But the authority did not provide further details, nor explained why it took more than a week to announce the problem.
Sinovac Biotech has been cooperating with Butantan, an institute at the State of Sao Paulo, to develop COVID-19 vaccines, called CoronaVac. The institute was surprised by ANVISA's decision, said it said was investigating the incident and will held a press conference on Tuesday morning local time.
#China #Brazil #SaoPaulo #SinovacBiotech #Butantan #CoronaVac #ANVISA #COVID19 #WuhanVirus #Vaccine
Source: Stand News #Nov10
https://bit.ly/2H6uwYI
#WuhanPneumonia #Covid19 #Vaccine
Peru suspends clinical trials of Chinese COVID-19 vaccine as tester develops neurological problems
Source: Channel News Asia #Dec12
Read more
⬇️⬇️⬇️
Peru suspends clinical trials of Chinese COVID-19 vaccine as tester develops neurological problems
Source: Channel News Asia #Dec12
Read more
⬇️⬇️⬇️
#WuhanPneumonia #Covid19 #Vaccine
Peru suspends clinical trials of Chinese COVID-19 vaccine as tester develops neurological problems
Peru has temporarily suspended clinical trials of a COVID-19 vaccine made by Chinese drug giant #Sinopharm after detecting neurological problems in one of its test volunteers.
The National Institute of Health in Lima said on Dec 11, 2020 that it had decided to interrupt the trial after a volunteer had difficulty moving their arms, according to local media.
"Several days ago we signalled, as we are required, to the regulatory authorities that one of our participants (in trials) presented neurological symptoms which could correspond to a condition called Guillain-Barre syndrome," said chief researcher German Malaga in comments to the press.
Guillain-Barre syndrome is a rare and non-contagious disorder which affects the movement of the arms and legs. Peru declared a temporary health emergency in five regions in June last year following multiple cases.
In the 1970s a campaign to vaccinate Americans against a supposedly devastating strain of swine flu ground to a halt after about 450 of those vaccinated developed the syndrome, which can also cause paralysis.
Peru's clinical trials for the Sinopharm vaccine were due to conclude this week, after testing around 12,000 people.
Source: Channel News Asia #Dec12
https://www.channelnewsasia.com/news/world/peru-suspends-clinical-trials-china-sinopharm-covid-19-vaccine-13757116
#GuillainBarreSyndrome #Paralysis
Peru suspends clinical trials of Chinese COVID-19 vaccine as tester develops neurological problems
Peru has temporarily suspended clinical trials of a COVID-19 vaccine made by Chinese drug giant #Sinopharm after detecting neurological problems in one of its test volunteers.
The National Institute of Health in Lima said on Dec 11, 2020 that it had decided to interrupt the trial after a volunteer had difficulty moving their arms, according to local media.
"Several days ago we signalled, as we are required, to the regulatory authorities that one of our participants (in trials) presented neurological symptoms which could correspond to a condition called Guillain-Barre syndrome," said chief researcher German Malaga in comments to the press.
Guillain-Barre syndrome is a rare and non-contagious disorder which affects the movement of the arms and legs. Peru declared a temporary health emergency in five regions in June last year following multiple cases.
In the 1970s a campaign to vaccinate Americans against a supposedly devastating strain of swine flu ground to a halt after about 450 of those vaccinated developed the syndrome, which can also cause paralysis.
Peru's clinical trials for the Sinopharm vaccine were due to conclude this week, after testing around 12,000 people.
Source: Channel News Asia #Dec12
https://www.channelnewsasia.com/news/world/peru-suspends-clinical-trials-china-sinopharm-covid-19-vaccine-13757116
#GuillainBarreSyndrome #Paralysis
CNA
Peru suspends clinical trials of Chinese COVID-19 vaccine
Peru has temporarily suspended clinical trials of a Covid vaccine made by Chinese drug giant Sinopharm after detecting neurological problems in ...
The Brazilian President Jair Bolsonaro Continued to Criticize China's Vaccine with Low Effectiveness
The Sao Paulo State in Brazil planned to use the Wuhan Virus vaccine developed by Sinovac from China. But President Jair Bolsonaro continued to judge this vaccine, saying that its effectiveness was seemingly low.
Bolsonaro made a Christmas speech on the internet on Thursday saying "The effectiveness of the vaccine which used by Sao Paulo State is relatively low”. But he did not make further explanations. He also indicated earlier that he would not inject this vaccine.
Source from: Apple Daily #Dec25
https://hk.appledaily.com/international/20201225/XZOOEURQHBBHDENNGW6GVJMTQQ/
#Brazil #China #WuhanVirus #Vaccine #Sinovac #JairBolsonaro #COVID19
The Sao Paulo State in Brazil planned to use the Wuhan Virus vaccine developed by Sinovac from China. But President Jair Bolsonaro continued to judge this vaccine, saying that its effectiveness was seemingly low.
Bolsonaro made a Christmas speech on the internet on Thursday saying "The effectiveness of the vaccine which used by Sao Paulo State is relatively low”. But he did not make further explanations. He also indicated earlier that he would not inject this vaccine.
Source from: Apple Daily #Dec25
https://hk.appledaily.com/international/20201225/XZOOEURQHBBHDENNGW6GVJMTQQ/
#Brazil #China #WuhanVirus #Vaccine #Sinovac #JairBolsonaro #COVID19
Comparing to 3 other vaccines, SinoVac BioTech from China has the lowest effectiveness (50.38%), while the Moderna vaccine from the US has 94.1% effectiveness. Yet, the Hong Kong government purchases China's vaccine instead of America's.
#COVID19 #Vaccine #SinaVacBioTech #GoHKgraphics
#COVID19 #Vaccine #SinaVacBioTech #GoHKgraphics
Only 45.9% of the interviewees in Hong Kong are willing to be vaccinated, with less than 30% willing to receive Sinovac Biotech vaccine
#COVID19 #vaccine #SinovacBiotech #GoHKgraphics
#COVID19 #vaccine #SinovacBiotech #GoHKgraphics
Brazilian Health Authorities Criticise the Low Transparency of the Chinese Vaccine Emergency Use Standard
Whether using vaccine manufactured by the Chinese company Sinovac Biotech caused controversy in Brazil again and involved in Brazilian partisan debate.
ANVISA, a Brazilian Health Regulatory Agency, expressed their concerns over the COVID-19 vaccines on Monday as the Chinese public health departments approved the vaccine for emergency use without adequate transparency of the policy standards.
Jair Bolsonaro, the President of Brazil, has always criticised the Chinese vaccine that the “origin” of vaccine is not trustworthy. However, his political opponent, Sao Paulo Governor João Doria, who is regarded as the most capable of challenging the presidency in the 2022 presidential election, his state's research institute, is currently developing the vaccine CoronaVac with Sinovac. Doria even mentioned that they expect to distribute the vaccines to the local residents in January 2021.
#Vaccine #COVID19 #CovidVaccine #JoãoDoria #JairBolsonaro #SinovacBiotech #Brazil #ANVISA
Source: Stand News #Dec15
https://bit.ly/3ucWGEW
Whether using vaccine manufactured by the Chinese company Sinovac Biotech caused controversy in Brazil again and involved in Brazilian partisan debate.
ANVISA, a Brazilian Health Regulatory Agency, expressed their concerns over the COVID-19 vaccines on Monday as the Chinese public health departments approved the vaccine for emergency use without adequate transparency of the policy standards.
Jair Bolsonaro, the President of Brazil, has always criticised the Chinese vaccine that the “origin” of vaccine is not trustworthy. However, his political opponent, Sao Paulo Governor João Doria, who is regarded as the most capable of challenging the presidency in the 2022 presidential election, his state's research institute, is currently developing the vaccine CoronaVac with Sinovac. Doria even mentioned that they expect to distribute the vaccines to the local residents in January 2021.
#Vaccine #COVID19 #CovidVaccine #JoãoDoria #JairBolsonaro #SinovacBiotech #Brazil #ANVISA
Source: Stand News #Dec15
https://bit.ly/3ucWGEW
#MadeinChina #WuhanPneumonia
72-year-old man in Hong Kong Suffers hypertension and heart palpitation after China-made #Sinovec Jab
On Feb 27, 2021, a 72-year-old man in Hong Kong was hospitalized after receiving the China-made Sinovec #covid19 vaccinations.
The man suffered hypertension and heart palpitation. It was reported his pulse went up to 100 beats per minute.
He wss among 7,000 people who received Covid-19 vaccinations. The incident happened at a vaccination center operared by #VirtusMedical and the Association of Private Medical Specialists of Hong Kong. The man was sent to Queen Elizabeth Hospital.
According to the government, the China-made Sinovac vaccine is the only vaccine available in Hong Kong at the moment.
Source: Apple Daily; RTHK #Feb27
https://bit.ly/3ku6hCR
https://news.rthk.hk/rthk/en/component/k2/1577893-20210227.htm
#Vaccine #Hypertension
72-year-old man in Hong Kong Suffers hypertension and heart palpitation after China-made #Sinovec Jab
On Feb 27, 2021, a 72-year-old man in Hong Kong was hospitalized after receiving the China-made Sinovec #covid19 vaccinations.
The man suffered hypertension and heart palpitation. It was reported his pulse went up to 100 beats per minute.
He wss among 7,000 people who received Covid-19 vaccinations. The incident happened at a vaccination center operared by #VirtusMedical and the Association of Private Medical Specialists of Hong Kong. The man was sent to Queen Elizabeth Hospital.
According to the government, the China-made Sinovac vaccine is the only vaccine available in Hong Kong at the moment.
Source: Apple Daily; RTHK #Feb27
https://bit.ly/3ku6hCR
https://news.rthk.hk/rthk/en/component/k2/1577893-20210227.htm
#Vaccine #Hypertension
The vaccination project has started the online booking since Feb 23, having 29 community vaccination centres with 2 different types of vaccines for injection.
#COVID19 #Vaccine #SincovacBiotech #BioNTech #GoHKgraphics
#COVID19 #Vaccine #SincovacBiotech #BioNTech #GoHKgraphics
The 1st death case after vaccination in Hong Kong was recorded on 28/2, but the Hospital Authority held a press briefing 3 days after the incident.
#COVID19 #SinovacBiotech #Vaccine #HospitalAuthority #GoHKgraohics
#COVID19 #SinovacBiotech #Vaccine #HospitalAuthority #GoHKgraohics
#Vaccination #MassCancellation
Hong Kong Govt blames "smear campaign" as seniors cancel vaccination bookings in droves
The Hong Kong government issued a statement, accusing an unnamed medical professional group of "smearing" the government's vaccination program.
The Health Authority Employees Alliance (#HAEA) responded in a facebook post on March 18, 2021, reiterating their criticisms against the vaccination program. The medical workers' group pointed out again that the third-stage data remains insufficient for the Sinovac vaccine on patients above 60 years of age. Therefore they remain opposed to the Hong Kong government's call for citizens to receive the made-in-China Sinovac vaccine.
The group stressed that they had never been opposed to vaccination in general.
Meanwhile, the numerous deaths following vaccinations seem to have shaken the faith in the vaccine among senior citizens, although the government's expert committee insisted that the deaths are not directly related.
Speaking on a radio show on the public broadcaster RTHK, Lin Wai-yiu of the Society for Community Organization noted that they had been assisting seniors with vaccine-related inquiries. In the beginning of the program, most inquiries came from those who wanted to take the vaccine. Recently, however, half of the seniors who called wanted to cancel their appointments.
"They're cancelling in droves," Lin said. "Perhaps they read about the severe cases, and they were concerned whether their health condition is suitable for the vaccine."
He added that the government had cautioned that those with chronic illnesses should be be careful with the vaccine, but 70% of seniors often have some chronic illnesses. Additionally, some of them do not have the ability to make a medical judgment and cannot evaluate the risks involved; they would cancel their booking first, and make a decision later after consulting with their doctor.
Source: Stand News #Mar18
https://www.thestandnews.com/society/政府譴責抹黑疫苗-醫管局員工陣線反駁-科興數據未盡充分-社協-半數查詢長者望取消打針/
#FailedState #Vaccine #CoronavirusPandemic #WuhanPneumonia
Hong Kong Govt blames "smear campaign" as seniors cancel vaccination bookings in droves
The Hong Kong government issued a statement, accusing an unnamed medical professional group of "smearing" the government's vaccination program.
The Health Authority Employees Alliance (#HAEA) responded in a facebook post on March 18, 2021, reiterating their criticisms against the vaccination program. The medical workers' group pointed out again that the third-stage data remains insufficient for the Sinovac vaccine on patients above 60 years of age. Therefore they remain opposed to the Hong Kong government's call for citizens to receive the made-in-China Sinovac vaccine.
The group stressed that they had never been opposed to vaccination in general.
Meanwhile, the numerous deaths following vaccinations seem to have shaken the faith in the vaccine among senior citizens, although the government's expert committee insisted that the deaths are not directly related.
Speaking on a radio show on the public broadcaster RTHK, Lin Wai-yiu of the Society for Community Organization noted that they had been assisting seniors with vaccine-related inquiries. In the beginning of the program, most inquiries came from those who wanted to take the vaccine. Recently, however, half of the seniors who called wanted to cancel their appointments.
"They're cancelling in droves," Lin said. "Perhaps they read about the severe cases, and they were concerned whether their health condition is suitable for the vaccine."
He added that the government had cautioned that those with chronic illnesses should be be careful with the vaccine, but 70% of seniors often have some chronic illnesses. Additionally, some of them do not have the ability to make a medical judgment and cannot evaluate the risks involved; they would cancel their booking first, and make a decision later after consulting with their doctor.
Source: Stand News #Mar18
https://www.thestandnews.com/society/政府譴責抹黑疫苗-醫管局員工陣線反駁-科興數據未盡充分-社協-半數查詢長者望取消打針/
#FailedState #Vaccine #CoronavirusPandemic #WuhanPneumonia
International Olympics Commission Purchasing Chinese Vaccines. Japan’s Olympic Minister: Did Not Know about This Beforehand and Japanese Athletes Will Not Be Administered with the Chinese Vaccines
According to a report from Asahi Shimbun, after attending a cabinet meeting on 12th March, Japan’s Olympic Minister Tamayo Marukawa was asked by reporters about International Olympics Commission (IOC) Chairperson Thomas Bach’s announcement of purchasing COVID-19 vaccines from China. Marukawa indicated that she did not know about this beforehand. She said there is no arrangement with IOC and no adjustments are needed regarding this issue. She also emphasized that having received COVID-19 vaccines will not be a prerequisite for participating in the Tokyo Olympics, that this principle remains the same. Marukawa further indicated that the Japanese government does not have more information about this issue, that “all the information we know is from IOC’s website and reports from news media”.
#Olympics #China #Japan #Vaccine #COVID19 #VaccineDiplomacy
Source: Stand News #Mar12
https://bit.ly/3c79oy9
According to a report from Asahi Shimbun, after attending a cabinet meeting on 12th March, Japan’s Olympic Minister Tamayo Marukawa was asked by reporters about International Olympics Commission (IOC) Chairperson Thomas Bach’s announcement of purchasing COVID-19 vaccines from China. Marukawa indicated that she did not know about this beforehand. She said there is no arrangement with IOC and no adjustments are needed regarding this issue. She also emphasized that having received COVID-19 vaccines will not be a prerequisite for participating in the Tokyo Olympics, that this principle remains the same. Marukawa further indicated that the Japanese government does not have more information about this issue, that “all the information we know is from IOC’s website and reports from news media”.
#Olympics #China #Japan #Vaccine #COVID19 #VaccineDiplomacy
Source: Stand News #Mar12
https://bit.ly/3c79oy9
#FailedState
Hong Kong Doctors Criticize the Government for Delayed Information, As Guidelines Arrives Half a Month after #Vaccination Program Begins
In Hong Kong, there were at least 7 deaths following the China-made #Sinovac #COVID19 vaccination. On March 15, 2021, the Hong Kong government's Department of Health finally released an "Interim Guidance Notes" regarding the China-made vaccines for medical doctors, nearly 3 weeks after the vaccination program has begun.
The guidelines include a list of conditions under which people should not receive the vaccine, including those who had a history of allergic reaction to other Covid19 vaccine, inactivated vaccine, or any other vaccines in general; those with severe neurological conditions; uncontrolled severe chronic illnesses; as well as pregnant and breastfeeding women.
The chairperson of the Public Doctors Association (#HKPDA) in Hong Kong, Dr. Ma Chung-yee, noted that the newly-released guidelines actually consisted mostly of old information.She said that it did not read like a professional document for practicing doctors.
Another private doctor who wished to remain anonymous criticized that the guidelines has "no help at all" to practitioners. He accused the government for passing on the medical liabilities to frontline doctors, making them responsible for verifying that patients didn't have any of the described conditions before administering the vaccine.
Since the vaccination program began on Feb 26, 2021, there had been no government-issued guidelines until this interim document; some doctors have been criticizing that the required information is coming too slowly.
According to Dr. Ivan Hung, chairperson of the government's "Expert Committee on Clinical Events Assessment following COVID-19 Immunization", the delay was caused by the time they needed to gather the relevant information.
Source: Stand News #Mar15
https://www.thestandnews.com/politics/%E6%AD%A6%E6%BC%A2%E8%82%BA%E7%82%8E-%E8%A1%9E%E7%94%9F%E7%BD%B2%E7%99%BC%E7%A7%91%E8%88%88%E6%8C%87%E5%BC%95-%E6%9B%BE%E4%B8%AD%E9%A2%A8%E6%88%96%E6%80%A5%E6%80%A7%E5%BF%83%E8%82%8C%E6%A2%97%E5%A1%9E%E6%87%89%E6%9A%AB%E7%B7%A9%E6%8E%A5%E7%A8%AE-%E9%A6%AC%E4%BB%B2%E5%84%80-%E6%96%B0%E6%8C%87%E5%BC%95%E5%A4%A7%E5%A4%9A%E8%88%8A%E6%9C%89%E8%B3%87%E6%96%99/
#Vaccine #Guidelines #VaccinationDeath #HealthAuthorities #PregnantWomen
Hong Kong Doctors Criticize the Government for Delayed Information, As Guidelines Arrives Half a Month after #Vaccination Program Begins
In Hong Kong, there were at least 7 deaths following the China-made #Sinovac #COVID19 vaccination. On March 15, 2021, the Hong Kong government's Department of Health finally released an "Interim Guidance Notes" regarding the China-made vaccines for medical doctors, nearly 3 weeks after the vaccination program has begun.
The guidelines include a list of conditions under which people should not receive the vaccine, including those who had a history of allergic reaction to other Covid19 vaccine, inactivated vaccine, or any other vaccines in general; those with severe neurological conditions; uncontrolled severe chronic illnesses; as well as pregnant and breastfeeding women.
The chairperson of the Public Doctors Association (#HKPDA) in Hong Kong, Dr. Ma Chung-yee, noted that the newly-released guidelines actually consisted mostly of old information.She said that it did not read like a professional document for practicing doctors.
Another private doctor who wished to remain anonymous criticized that the guidelines has "no help at all" to practitioners. He accused the government for passing on the medical liabilities to frontline doctors, making them responsible for verifying that patients didn't have any of the described conditions before administering the vaccine.
Since the vaccination program began on Feb 26, 2021, there had been no government-issued guidelines until this interim document; some doctors have been criticizing that the required information is coming too slowly.
According to Dr. Ivan Hung, chairperson of the government's "Expert Committee on Clinical Events Assessment following COVID-19 Immunization", the delay was caused by the time they needed to gather the relevant information.
Source: Stand News #Mar15
https://www.thestandnews.com/politics/%E6%AD%A6%E6%BC%A2%E8%82%BA%E7%82%8E-%E8%A1%9E%E7%94%9F%E7%BD%B2%E7%99%BC%E7%A7%91%E8%88%88%E6%8C%87%E5%BC%95-%E6%9B%BE%E4%B8%AD%E9%A2%A8%E6%88%96%E6%80%A5%E6%80%A7%E5%BF%83%E8%82%8C%E6%A2%97%E5%A1%9E%E6%87%89%E6%9A%AB%E7%B7%A9%E6%8E%A5%E7%A8%AE-%E9%A6%AC%E4%BB%B2%E5%84%80-%E6%96%B0%E6%8C%87%E5%BC%95%E5%A4%A7%E5%A4%9A%E8%88%8A%E6%9C%89%E8%B3%87%E6%96%99/
#Vaccine #Guidelines #VaccinationDeath #HealthAuthorities #PregnantWomen
The Hong Kong Government was indecisive on BioNTech vaccination, and over a thousand citizens still received the related vaccine in the morning of the vaccine ban.
#BioNTech #COVID19 #Vaccine #Pfizer #GoHKgraphics
#BioNTech #COVID19 #Vaccine #Pfizer #GoHKgraphics
2 more death cases, aged 60 and 80, were found after the Sinovac Biotech vaccination. Up to March 24, 2021, there are 10 post-vaccination death cases in total in Hong Kong, but none was said related to the vaccine.
#SinovacBiotech #COVID19 #vaccine #GoHKgraphics
#SinovacBiotech #COVID19 #vaccine #GoHKgraphics
WHO Experts Review the Severe Side Effects Data of Sinovac, Commented "Low Credibility" for Elderly
WHO experts indicated 5 May that the Chinese Sinovac for COVID-19 has protection to adults who are under 60. However, there is a lack of data on the risk of serious side effects from vaccines, with “low credibility” for patients over aged 60 and with chronic illnesses. The expert group even referred to the severe side effect data of Sinovac on the elderly and patients with chronic illness as “very low” credibility.
The Strategic Advisory Group of Experts on Immunization (SAGE) in WHO evaluated the Phase 3 clinical test data of Sinovac in China, Brazil, Indonesia, Turkey, and Chile. They are very confident about the effectiveness of two doses of Sinovac in preventing adults aged 18-59, moderately confident about the severe side effect data on adults aged 59 years or younger. However, for those aged 60 years or older and patients with chronic diseases, the risk data of patients with severe side effects after vaccination is classified as “low credibility”, which means that the test data of Sinovac cannot determine the risks of serious side effects of Sinovac on the elderly and patients.
Source: Stand News #May06
https://bit.ly/3tKkLl3
#WHO #Vaccine #SAGE #COVID19 #China #Sinovac #Brazil #Indonesia #Turkey #Chile #Credibility #Phase3ClinicalTest
WHO experts indicated 5 May that the Chinese Sinovac for COVID-19 has protection to adults who are under 60. However, there is a lack of data on the risk of serious side effects from vaccines, with “low credibility” for patients over aged 60 and with chronic illnesses. The expert group even referred to the severe side effect data of Sinovac on the elderly and patients with chronic illness as “very low” credibility.
The Strategic Advisory Group of Experts on Immunization (SAGE) in WHO evaluated the Phase 3 clinical test data of Sinovac in China, Brazil, Indonesia, Turkey, and Chile. They are very confident about the effectiveness of two doses of Sinovac in preventing adults aged 18-59, moderately confident about the severe side effect data on adults aged 59 years or younger. However, for those aged 60 years or older and patients with chronic diseases, the risk data of patients with severe side effects after vaccination is classified as “low credibility”, which means that the test data of Sinovac cannot determine the risks of serious side effects of Sinovac on the elderly and patients.
Source: Stand News #May06
https://bit.ly/3tKkLl3
#WHO #Vaccine #SAGE #COVID19 #China #Sinovac #Brazil #Indonesia #Turkey #Chile #Credibility #Phase3ClinicalTest